Injectable Drug Delivery Resources
-
A Technical Package That Serves On-Time Injectable Project Completion
4/24/2023
The accuracy, robustness, and completeness of the technical package an organization submits to its development and/or manufacturing partner is critical to meeting fill project timelines.
-
Exploring Lipid Nanoparticles For Drug Delivery
11/11/2022
Using lipid nanoparticles (LNP) for drug delivery is a promising area of research. Discover the benefits of LNP delivery, the different types of lipid nanoparticles, their safety for drug delivery, and more.
-
Characterizing The E&L Profile Of Stoppers For Drug Stability
6/11/2024
The significance of E&L testing lies in its ability to identify potential risks associated with the use of containers and packaging materials in the pharmaceutical industry.
-
Achieving New Heights By Expanding Services, Talent, And Facilities
4/20/2023
As you aim to reduce costs and ensure on-time delivery, discover the opportunities for drug formulation and commercial supply that can advance your therapy to the clinic and beyond.
-
Delivering Market Success For Pharma Partners From Concept To Patient
The development of drug delivery devices that are innovative, intuitive, patient friendly, and patient safe must address certain areas of concern that are particular to both biologic and biosimilar therapies.
-
Containment Solutions To Help Emerging Biologic Companies
3/24/2023
Set up your small company for long-term success using packaging containment offerings and services to help mitigate risks and speed up your time to market.
-
Solubility With Lipid-Based Technologies For Oral & Injectable Formulations
11/7/2022
Innovative approaches in developing formulations can help to improve a drug's safety and efficacy. Explore the decision for selecting the best-suited technology for formulating a complex molecule.
-
Zero-Stress Low Volume Aseptic Filling For Solids And Liquids
6/26/2023
Aseptic filling technology is of utmost importance. Explore in great detail an aseptic filling solution that has been specifically designed for laboratory and R&D applications in the pharmaceutical industry.
-
CDMOs Step Up Parenteral Manufacturing Support
7/4/2022
Jeff Clement, Executive Director, CDMO Business Development North America, discusses the impact of the pandemic on CDMOs and parenteral market trends.
-
Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization
2/20/2024
While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.